Evaluation of the Efficiency of Bone Born Intra Oral Distractor for Closure of Wide Alveolar Cleft (BBID-WAC)

January 4, 2026 updated by: Hanaa Elmorsy, Faculty of Dental Medicine for Girls
The study aimed to determine efficiency of Bone-Born Intraoral Distractor on wide Alveolar cleft patients

Study Overview

Status

Completed

Detailed Description

Stereographic models were used for construction of bone-born custom-made intraoral distractor according to the inclusion and exclusion criteria, followed up to measure and determine the efficiency of the distractor

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cairo Governorate
      • Cairo, Cairo Governorate, Egypt, 12345
        • Faculty of oral and dental medicine for Girls AlAzhar University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with wide alveolar clefts more than 8ml either unilateral or bilateral or median facial cleft.
  • Patients who had previous failed grafting also may be included.
  • Age range of patients 7-20 years old, with no gender prediction, able to read and sign the informed consent (parents)
  • Patients with median facial clefts.

Exclusion Criteria:

  • Narrow alveolar cleft
  • Syndromic patients.
  • Oral soft tissues defects, inflammation, infections and bone metabolism disturbance.
  • Allergy to titanium implant.
  • Patient with systemic disease and immunocompromised patient.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Bone-Borne Intra-oral distractor
Surgeries to fix the device were conducted under GA. Then latency period of seven days was applied. Activation was 0.5 mm twice a day. The transport segment touched the docking site then the Consolidation period is achieved. Follow up for 6 months.
Evaluation of the efficiency of the Bone-Borne Intraoral distractors on wide Alveolar cleft

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in alveolar cleft defect area measured by cone-beam computed tomography (CBCT) (minimum value: 0 mm²; no predefined maximum value; lower values indicate better outcome)
Time Frame: 6 months postoperative follow up
The alveolar cleft defect area will be quantitatively measured using cone-beam computed tomography (CBCT). Preoperative and postoperative CBCT scans will be superimposed to calculate the change in defect area following distraction osteogenesis.
6 months postoperative follow up
Change in tooth mobility assessed using Miller's Tooth Mobility Index (minimum score: 0; maximum score: 3; higher scores indicate worse mobility)
Time Frame: 6 months postoperative follow up
Tooth mobility will be clinically evaluated using Miller's Tooth Mobility Index to detect and grade the degree of mobility before and after treatment.
6 months postoperative follow up
Vitality of the transported bone segment assessed by clinical vitality indicators after transport distraction osteogenesis (binary outcome: viable / non-viable; viable outcome indicates better result)
Time Frame: 6 months follow up
Vitality of the transported disk after transport distraction osteogenesis is measured through clinical indicators as No infection, No pain or inflammation, Stable transported segment, Successful consolidation phase.
6 months follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Hanaa Elmorsy, Assis.Lec, Assistant lecturer of OMFs department Azhar University
  • Study Director: Susan H Abdel Hakim, professor, Professor of OMFs department azhar university
  • Study Director: Wael Shawkat, Consultant, Head of the department at the Health Insurance Hospital
  • Study Director: Fatema khalifa, Assist.Prof, Assistant Professor of OMFs Azhar university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2023

Primary Completion (Actual)

June 29, 2025

Study Completion (Actual)

December 1, 2025

Study Registration Dates

First Submitted

November 30, 2025

First Submitted That Met QC Criteria

December 13, 2025

First Posted (Estimated)

December 29, 2025

Study Record Updates

Last Update Posted (Actual)

January 7, 2026

Last Update Submitted That Met QC Criteria

January 4, 2026

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • ORSUR-10

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Detailed Protocol

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alveolar Cleft

Clinical Trials on Bone-borne Intra oral distractor

Subscribe